Patents Assigned to XEL Herbaceuticals, Inc.
  • Patent number: 7232585
    Abstract: Green tea formulations and methods for the preparation thereof are shown and described. Generally speaking, the method of preparation includes the mixing of fresh tea leaves in an amount of cold water, followed by pulverization of the leaves to release their intracellular material from the cells of the green tea leaves into the water and form an aqueous extract component. The remaining cellular material forms a leaf residue component which is removed from the mixture. Once the leaf residue is removed, the aqueous extract component is collected and may be dried or further processed to produce a final tea extract that has good natural color, robust natural flavor, and pleasant organoleptic properties, which also is high in polyphenol content, and may be used for various purposes such as the creation of a green tea beverage.
    Type: Grant
    Filed: June 24, 2004
    Date of Patent: June 19, 2007
    Assignee: Xel Herbaceuticals, Inc.
    Inventors: Danyi Quan, Wade W. Xiong
  • Patent number: 6896898
    Abstract: The present invention provides a composition of transdermally administered aconitine alkaloids for ameliorating pain and inflammation. In one aspect, an aconitine alkaloid is delivered in a sufficient amount to achieve and maintain a blood plasma aconitine alkaloid level of about 0.5 ng/mL to about 400 ng/mL. Aconitine alkaloids may be delivered by themselves, or in combination with other elements, such as additional analgesics, other drugs, or positive health promoting substances. Various formulations for the transdermal delivery of aconitine alkaloids are disclosed, and may include selected penetration enhancers.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: May 24, 2005
    Assignee: XEL Herbaceuticals, Inc.
    Inventors: Weihong Xiong, Dinesh C. Patel
  • Patent number: 6299925
    Abstract: A solid state water soluble formulation in granular or tablet form is provided. The formulation is a natural products formulation containing a green tea plant extract in combination with other ingredients which create an effervescent liquid composition upon dispensing the formulation in a liquid. The liquid form of administration, as well as the effervescent properties of the dissolved formulation increase bioavailability of the advantageous components of the green tea plants such as Polyphenols, by increasing absorption speed and amount in the human body. The formulation may include additional components such as, other plant extracts, vitamins, ionic minerals, and other substances purported to be of a health benefit.
    Type: Grant
    Filed: June 29, 1999
    Date of Patent: October 9, 2001
    Assignee: XEL Herbaceuticals, Inc.
    Inventors: Weihong Xiong, Danyi Quan, Dinesh C. Patel